Frans A van Nieuwenhoven Selected Research

Frans A van Nieuwenhoven Research Topics

Disease

8	Fibrosis (Cirrhosis) 12/2018 - 12/2003
8	Diabetic Nephropathies (Diabetic Nephropathy) 11/2008 - 12/2003
5	Heart Failure 01/2023 - 02/2009
5	Hypertrophy 12/2018 - 09/2010
3	Inflammation (Inflammations) 01/2014 - 04/2008
3	Albuminuria 11/2008 - 05/2004
2	Cardiomegaly (Heart Hypertrophy) 11/2021 - 04/2008
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2018 - 11/2017
2	Infarction (Infarctions) 11/2017 - 03/2013
2	Body Weight (Weight, Body) 01/2014 - 02/2012
2	Cicatrix (Scar) 03/2013 - 10/2006
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Bundle-Branch Block (Fascicular Block) 01/2022
1	Atrial Remodeling 01/2022
1	Insulin Resistance 11/2021
1	Diabetic Cardiomyopathies 11/2021
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2018
1	Myocardial Infarction 11/2017
1	Hypertension (High Blood Pressure) 01/2014
1	Heart Diseases (Heart Disease) 10/2010
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2010
1	Atherosclerosis 10/2010
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2008
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2008
1	Diabetic Retinopathy (Retinopathy, Diabetic) 10/2006
1	Epiretinal Membrane (Epiretinal Membranes) 10/2006
1	Proliferative Vitreoretinopathy 10/2006
1	Retinal Perforations 10/2006
1	Proteinuria 05/2004
1	Diabetes Complications 05/2004

Drug/Important Bio-Agent (IBA)

8	Connective Tissue Growth FactorIBA 11/2008 - 05/2004
3	Angiotensin IIIBA 01/2018 - 01/2014
3	Messenger RNA (mRNA)IBA 11/2017 - 11/2008
3	Glucose (Dextrose)FDA LinkGeneric 01/2014 - 12/2003
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2013 - 12/2003
2	LipidsIBA 11/2021 - 10/2010
2	MicroRNAs (MicroRNA)IBA 01/2018 - 08/2017
2	Proteins (Proteins, Gene)FDA Link 11/2017 - 11/2008
2	CytokinesIBA 03/2013 - 06/2005
2	Matrix Metalloproteinases (MMPs)IBA 03/2013 - 11/2008
2	AlbuminsIBA 02/2012 - 01/2006
2	Insulin-Like Growth Factor I (IGF-1)IBA 09/2010 - 12/2003
2	EnzymesIBA 10/2006 - 06/2005
2	ImmunosorbentsIBA 10/2006 - 06/2005
2	Biomarkers (Surrogate Marker)IBA 01/2006 - 05/2004
2	CreatinineIBA 06/2005 - 05/2004
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2022
1	Leucine (L-Leucine)FDA Link 11/2021
1	Arginine (L-Arginine)FDA Link 11/2021
1	Amino Acids FDA Link 11/2021
1	Adenosine Triphosphatases (ATPase)IBA 11/2021
1	Lysine (L-Lysine)FDA Link 11/2021
1	Natriuretic PeptidesIBA 01/2021
1	Contractile ProteinsIBA 12/2018
1	CalciumIBA 12/2018
1	Ion Channels (Ion Channel)IBA 12/2018
1	AMP-Activated Protein KinasesIBA 01/2014
1	Advanced Glycation End ProductsIBA 01/2014
1	ChemokinesIBA 03/2013
1	Blood Glucose (Blood Sugar)IBA 02/2012
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 02/2012
1	CollagenIBA 02/2012
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2010
1	LigandsIBA 10/2010
1	Transforming Growth Factors (Transforming Growth Factor)IBA 09/2010
1	Fatty Acids (Saturated Fatty Acids)IBA 02/2009
1	Bone Morphogenetic Protein 7IBA 11/2008
1	PPAR alphaIBA 04/2008
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 06/2005
1	Edetic Acid (EDTA)FDA Link 06/2005
1	Losartan (Cozaar)FDA LinkGeneric 06/2005
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2003

Therapy/Procedure

2	Cardiac Resynchronization Therapy 01/2023 - 08/2017
1	Radiofrequency Ablation 01/2022
1	Cautery 01/2022
1	Therapeutics 02/2009